Goldman Sachs downgrades Spotify stock to Neutral on balanced risk/reward

Goldman Sachs downgraded Spotify (SPOT) to Neutral from Buy, despite a slight price target increase to $770, citing a balanced risk/reward profile given that much of its projected mid-teens revenue growth and margin improvements are already priced into the stock's elevated 161x P/E ratio. This downgrade, ahead of Q3 2025 earnings on November 4 and following a Q2 miss, contrasts with other firms like HSBC, BNP Paribas Exane, and Guggenheim, which maintain Buy/Outperform ratings with higher price targets, emphasizing Spotify's product development and pricing power.

Analysis

Goldman Sachs has downgraded Spotify (SPOT) to Neutral from Buy, signaling a balanced risk/reward profile at its current valuation despite a slight price target increase to $770. The core of the downgrade rests on the stock's high P/E ratio of 161x, suggesting that Spotify's strong growth prospects are already priced in. This view is held even as Goldman projects a mid-teens percentage revenue CAGR over the next 3-4 years and anticipates annual gross margin expansion of 100-150 basis points, supported by pricing power and new revenue streams. The cautionary stance follows a reported miss on both EPS and revenue for Q2 2025, adding a layer of execution risk. However, there is a significant divergence in sell-side sentiment, with HSBC, BNP Paribas Exane, and Guggenheim maintaining Buy/Outperform ratings and setting higher price targets of $814, $900, and $850, respectively. These firms emphasize Spotify's market leadership, product innovation such as a new messaging feature, and pricing power as key drivers for future upside, creating a clear debate between strong fundamentals and a potentially stretched valuation.

Key Decisions for Investors

• Given the stock's elevated 161x P/E ratio and Goldman's view that future growth is priced in, investors should treat the upcoming Q3 earnings report on November 4 as a key validation point for the current valuation, especially following the Q2 miss.
• Evaluate the starkly divergent analyst opinions, weighing Goldman's valuation-based caution against the bullish product and pricing power arguments from firms like HSBC and BNP Paribas to determine alignment with one's own risk tolerance.
• Consider trimming positions to manage risk due to the balanced risk/reward profile cited by Goldman, while investors with high conviction in the long-term growth story may view any price weakness as a potential accumulation opportunity.